Legal Challenge Against Colorado Drug Price Controls Pits State Initiatives Against Federal Patent Law

The U.S. Chamber of Commerce and a prominent pharmaceutical industry group have urged a Colorado federal court to bar a state review board from setting price controls on prescription drugs, arguing that the practice is “irreconcilable” with federal patent law. This move comes amid heightened debate over regulatory measures designed to curb rising drug costs. The legal challenge posits significant implications for the balance between state-level healthcare initiatives and federally mandated intellectual property protections. For more details on this developing legal battle, you can refer to the article on Law360 here.